Enclomiphene vs TRT: Which One Fits Your Labs, Fertility Plans, and Budget?

We have commercial relationships with Male Excel and Taurus Meds. Those relationships do not change the facts or limitations we publish. Hone Health is included for comparison without an affiliate relationship.

Enclomiphene vs TRT mostly comes down to the cause of low testosterone and your fertility plans. Enclomiphene is a pill that raises LH and FSH so responsive testes can make more testosterone, and sperm concentration stayed in the normal range in 16-week trials. It is not FDA-approved. TRT replaces testosterone directly and can suppress sperm production.

That's the short answer. The useful part is figuring out which camp you're in. Below you'll find a three-question sort, what each path really costs in year one at three online programs we checked, and one thing our own commercial partner's website gets wrong.

Enclomiphene may be worth discussing if: you want kids someday (or you're not sure), your clinician thinks your testes can respond to higher LH/FSH signaling, and low testosterone has been properly confirmed alongside symptoms or signs.

TRT may be worth discussing if: testosterone replacement is clinically appropriate after a proper workup, fertility is not a near-term goal, or an endogenous-stimulation approach is not appropriate or has not helped your symptoms.

Hold off on both if: you're trying to conceive right now, you've had only one testosterone test, you've never had LH checked, or you have a red flag — very low testosterone with headaches or vision changes, a high PSA, a high red-blood-cell count, or a heart attack or stroke in the last six months.

The numbers that matter (checked September 20, 2026)

• One lab can change the conversation: LH (luteinizing hormone) helps distinguish primary from secondary hypogonadism and can affect whether a SERM approach is plausible.
• Enclomiphene online: Hone lists it from $42/month plus membership; its current Plus plan is $135/month after a $45 starting test. Taurus Meds advertises $149/month after a $49 start, but its terms also contain a conditional $17.99 recurring member-fee clause.
• TRT online: from $120/month for injections plus a $99/month membership and a $99 start fee at Male Excel.
• FDA-approved generic testosterone cypionate: discount-coupon prices can be low, but they vary by pharmacy, location, vial size, and date. The drug price is only part of the cost; visits and labs still matter.
• December 31, 2026: the current federal telemedicine flexibility for prescribing controlled medications such as testosterone is scheduled to expire unless it is extended or replaced. That specific federal controlled-substance rule does not govern enclomiphene, but state telemedicine and prescribing rules still can.

Enclomiphene vs TRT at a glance

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

This page is educational information, not medical advice. It doesn't diagnose low testosterone or interpret your lab results. If you have chest pain, sudden trouble breathing, or one leg that's suddenly swollen, red, or painful, call 911.

---

Enclomiphene vs TRT: what's actually different?

TRT adds testosterone from outside your body, so your brain turns down the signals (LH and FSH) that tell your testes to make testosterone and sperm. Enclomiphene blocks estrogen's "slow down" message in the brain, so those signals go up and your testes make more of their own testosterone. Both can raise testosterone in selected men, but they affect reproductive signaling in opposite directions.

Think of your brain as a thermostat and your testes as the furnace. The thermostat sends two signals. LH (luteinizing hormone) says "make testosterone." FSH (follicle-stimulating hormone) says "make sperm."

TRT is a space heater. The house gets warm fast. The thermostat notices and turns the furnace down. That's why testosterone goes up on TRT while your own production — and your sperm production — slows.

Enclomiphene is a cold pack on the thermostat. The thermostat thinks the house is chilly, so it tells the furnace to work harder. Your testes do the work.

Here's the catch. A cold pack only helps if the furnace works. If your testes are the problem, turning up the signal doesn't do much. Hold that thought — it's the whole LH story, and we'll come back to it.

Enclomiphene is not TRT (and it isn't "natural TRT")

Enclomiphene is a SERM (selective estrogen receptor modulator) — a drug that blocks estrogen's effect in some parts of the body. It's one of the two forms that make up clomiphene (Clomid), an older drug the FDA approved to help women ovulate. The other form, zuclomiphene, acts more like estrogen. Taking it out is the whole idea behind enclomiphene.

Some sales pages call enclomiphene "natural TRT." It isn't testosterone, it isn't natural, and it isn't testosterone replacement. It's a different drug with its own tradeoffs. (If you're comparing enclomiphene with the older combined drug, see our clomiphene reviews for men.)

What actually changes the decision

Sources: Wiehle et al., 2014; Kim et al., 2016; AUA testosterone guideline; TRAVERSE, NEJM 2023; BSSM 2026; DEA; DoD Operation Supplement Safety.

---

Which one fits you? Three questions sort most men

Three facts sort this better than any sales page: whether low testosterone has been properly confirmed alongside symptoms or signs, whether you might want kids, and whether your LH/FSH pattern points toward primary or secondary hypogonadism. Find your row in the table below. It tells you which conversation to have with a clinician — not which drug to demand.

Question 1: Has low testosterone actually been confirmed?

Total testosterone is the main number on a testosterone blood test. The American Urological Association (AUA) calls a total testosterone below 300 ng/dL "a reasonable cut-off" — but it says the diagnosis should only be made after two tests on separate days, both drawn early in the morning, plus symptoms or signs. The Endocrine Society says the same thing in its own words: symptoms plus consistently low levels, confirmed with a repeat morning test.

One finger-prick kit is a starting point, not a diagnosis. That matters more than it sounds. The AUA's own guideline notes that some studies estimate up to 25% of men who receive testosterone were never tested before starting. Don't start in that 25%.

Question 2: Might you want kids — ever?

This is the question that changes the most. The AUA and the American Society for Reproductive Medicine say that for a man interested in current or future fertility, clinicians should not prescribe testosterone.

Read that word again: future. If you're not sure whether you want kids, count yourself in the "maybe" group.

Question 3: Is your LH high, or low-to-normal?

The AUA says men with low testosterone and low or low-normal LH are candidates for SERM therapy. It does not set a single LH number that makes enclomiphene appropriate or inappropriate, and an elevated LH can point toward primary testicular dysfunction. That's a job for your clinician, not a chart.

Find your row

Built from: AUA testosterone deficiency guideline statements 2, 6, 7, 23, and 27; AUA/ASRM male infertility guideline statements 41 and 42; Endocrine Society guideline 1.3 and 2.2.

"Done with kids" doesn't automatically mean TRT

Taking fertility off the table removes one of the biggest tradeoffs. It doesn't settle the rest. You still need a confirmed diagnosis, a look at why your testosterone is low, and a treatment with evidence for the symptoms you actually want addressed. If you're done having kids but would rather not use a controlled substance, a SERM approach can still be a conversation when the clinical pattern makes endogenous stimulation plausible.

Not sure which row is yours? Find My TRT Path maps your situation to the right care route and the questions to ask before you pay — so you walk into your first consult knowing what to request. It's educational and non-diagnostic, and it doesn't guarantee a prescription.

Map my care route with Find My TRT Path →

---

What is LH, and why does it decide enclomiphene vs TRT?

LH (luteinizing hormone) is the signal your pituitary gland sends telling your testes to make testosterone. Enclomiphene raises that signal. A high LH with low testosterone can point toward primary testicular dysfunction, where a SERM response may be limited; a low or low-normal LH can point toward a secondary pattern and is one reason clinicians may consider a SERM.

Hypogonadism is the medical word for testes that don't make enough testosterone. Doctors sort it by where the problem sits:

The British Society for Sexual Medicine adds a caution: even within these groups, enclomiphene may have limited success in some men with primary or "functional" low testosterone (the kind tied to health problems like obesity or type 2 diabetes).

The labs to get before you choose

Bring this list to any lab or clinician:

1. Two early-morning total testosterone tests, on separate days, ideally at the same lab.
2. LH — helps distinguish a primary from a secondary pattern and can affect whether a SERM approach is plausible.
3. FSH — the signal for sperm production.
4. Prolactin — if your LH is low or normal. High prolactin can point to a pituitary problem.
5. Hematocrit — the share of your blood made of red cells. The AUA recommends measuring hemoglobin and hematocrit before testosterone therapy because testosterone can raise them.
6. PSA (prostate-specific antigen) — the AUA recommends measuring it in men over 40 before testosterone therapy.
7. A semen analysis — discuss this when fertility is an active concern or when a fertility specialist recommends a baseline.

Estradiol may be checked when clinically indicated, including in men who develop breast symptoms.

Sources: AUA testosterone guideline statements 2, 6, 7, 9, 10, 11, and 12; AUA/ASRM male infertility guideline statement 2.

Numbers that mean "see a specialist first"

• Testosterone under 150 ng/dL with a low or low-normal LH. The AUA says these men should get a pituitary MRI, whatever their prolactin level.
• Prolactin that stays high. The AUA says that needs an endocrine workup.
• Headaches, changes in your side vision, or loss of smell. These can be signs of a pituitary or hormone condition that no online program should treat first.

Does your online program's first test include LH?

This is the part most comparison pages skip. We read each program's own description of its starting test on September 20, 2026:

What to do: Ask which tests your clinician needs to distinguish primary from secondary hypogonadism and whether LH and FSH are part of that workup. Do not treat a consumer checklist as a substitute for a clinician-directed evaluation.

---

Enclomiphene vs TRT for fertility: what happens to sperm?

They push sperm production in opposite directions. Testosterone therapy lowers it, and U.S. urology guidelines say men who want kids now or later shouldn't be prescribed testosterone. Enclomiphene kept sperm counts in the normal range over 16 weeks in trials — encouraging, but not a promise of fertility, and men who started with low counts mostly stayed low.

What TRT does to sperm

When testosterone comes from outside, your brain dials down FSH and LH. Your testes need both to keep making sperm. That's why the AUA's testosterone guideline gives its strongest recommendation, backed by its highest evidence grade, against prescribing testosterone to men who are trying to conceive. The newer AUA/ASRM infertility guideline goes further: no testosterone for men interested in current or future fertility.

The same infertility guideline says current testosterone use has a major impact on sperm production. Recovery after stopping can occur, but the timing and completeness vary and should not be promised for an individual patient.

How long recovery can take after stopping TRT

The best-known recovery estimates come from healthy men in hormonal male-contraception studies, not from men treated for testosterone deficiency. A pooled analysis found recovery was usually gradual over months after stopping hormones, but those data should not be used to promise an individual's timeline (Liu et al., Lancet 2006).

Two cautions. First, those were healthy volunteers — the AUA notes there are no high-quality recovery studies in men who actually had low testosterone. Second, in a study of 66 men who became infertile after testosterone use, older age and longer use were both tied to slower recovery, even with specialist treatment (PMC5292276).

What the enclomiphene trials actually showed

• Phase II trial (Wiehle, 2014): Enclomiphene raised morning testosterone about as well as a 1% testosterone gel, and estradiol rose too. Unlike the gel, it raised LH and FSH, and sperm counts were conserved. But 9 of the 12 men who started with low sperm counts still had low counts at the end, whichever treatment they got.
• Two Phase III trials (Kim, 2016): Overweight men aged 18 to 60 with secondary low testosterone took enclomiphene, a 1.62% testosterone gel, or a placebo for 16 weeks. Testosterone rose with both treatments. LH and FSH went up on enclomiphene and down on the gel. Enclomiphene kept sperm concentration in the normal range; the gel caused a marked drop.

Sources: Wiehle et al., Fertility and Sterility 2014; Kim et al., BJU International 2016.

A normal sperm count isn't the same as a baby

The AUA/ASRM guideline points out that the ideal measure in fertility research is a live birth, but most male fertility trials use semen analysis instead, because the female partner adds so many other factors. The enclomiphene trials measured hormones and sperm. They didn't measure pregnancies. So "kept sperm in the normal range" is the honest claim. "Preserves your fertility" goes further than the data.

What sellers say vs what the studies show

We checked this against every company on this page, partners included:

If you're trying to conceive right now

Make fertility the main problem, not a side effect. Start with a reproductive urologist. The AUA/ASRM guideline says clinicians may use SERMs, hCG, aromatase inhibitors, or a combination for infertile men with low testosterone — a conditional recommendation based on low-certainty evidence. Those are specialist tools, chosen after a real workup. For a side-by-side of fertility-first options, see our fertility-first TRT care routes.

---

Which works better: enclomiphene or TRT?

For raising the testosterone number, both approaches can work in selected men. A 2025 systematic review of randomized SERM trials found substantial increases in total testosterone, but the evidence combines clomiphene and enclomiphene and does not prove that enclomiphene and TRT provide equivalent symptom benefit. Enclomiphene's evidence is strongest for hormone and sperm outcomes and remains short-term.

Sources: Hohl et al., Arch Endocrinol Metab 2025 (summary); BSSM 2026; AUA testosterone guideline statements 14 and 15; TRAVERSE.

That same 2025 review had a caveat worth knowing: a statistical check on the testosterone results was still inconclusive, and the authors called for longer, larger trials.

The regulators noticed the same gap. In June 2022, an FDA advisory committee voted 8 to 4 against adding enclomiphene to the permanent list of substances pharmacies may compound, and several members who voted no pointed to a lack of clinical efficacy evidence (FDA meeting minutes). That doesn't mean enclomiphene does nothing. It means that, in the committee's view, the evidence for real clinical benefit hadn't been shown.

"My numbers went up, but I don't feel any better"

It can happen on either path, and it's worth taking seriously instead of just chasing a higher number. Low energy and fatigue have many causes — sleep, stress, depression, other medical problems — and even for TRT, the AUA calls evidence on energy and fatigue inconclusive. The AUA specifically advises discussing cessation of testosterone therapy when testosterone normalizes but symptoms do not improve after three to six months; that statement should not be automatically transferred to enclomiphene.

How fast does each one work?

In an early trial, men with low testosterone had significant increases in testosterone after two weeks on enclomiphene. How quickly symptoms change is less certain. For TRT, the AUA recommends follow-up testosterone measurement after an appropriate interval and says clinicians should discuss stopping when levels normalize but symptoms do not improve after three to six months.

If you're comparing an online enclomiphene path

TRT Provider Guide has commercial relationships with Male Excel and Taurus Meds. Hone Health appears here because its current public program offers both enclomiphene and testosterone paths and publishes unusually detailed testing information; direct Hone links on this page are research links, not paid recommendations. See How We Review TRT Providers.

If you want kids someday, your LH isn't high, and two morning tests confirmed low testosterone, enclomiphene is the path to discuss — and Hone Health is where we'd start. Hone prescribes single-ingredient enclomiphene from $42 a month plus membership, says in writing that it isn't recommended for men with high LH, and offers testosterone therapy in the same membership if enclomiphene isn't enough. You won't have to start over somewhere new.

Want to compare the actual testing and medication menu? Review Hone's current men's hormone program → This is a research link, not a paid recommendation. Treatment requires a clinician evaluation and a prescription when appropriate.

---

Is enclomiphene FDA-approved? What about TRT? (2026 status)

No enclomiphene drug product is FDA-approved. In the U.S., the online programs discussed here offer prescription compounded enclomiphene, and FDA's current 503A materials continue to list enclomiphene citrate among substances under evaluation. Many testosterone products are FDA-approved, while compounded testosterone products are not FDA-approved. Testosterone is a Schedule III controlled substance; enclomiphene is not federally scheduled as a controlled substance.

Two terms, in plain English:

• FDA-approved means the exact product went through FDA review for safety, effectiveness, and manufacturing quality for a specific use.
• Compounded means a pharmacy made the medication itself, usually for individual prescriptions. Compounded drugs aren't FDA-approved and haven't been through that review.
• Schedule III is a federal category for drugs with some abuse potential. Testosterone is on it, alongside anabolic steroids and ketamine (DEA).

The timeline that explains where things stand

Sources: FDA PCAC minutes; FDA labeling changes, 2025; Federal Register, DEA extension; DoD OPSS; BSSM; FDA notice, April 2026; FDA 503A list; HHS, June 2026.

Why enclomiphene is available if it isn't approved

The 2022 vote sounds like a ban. It wasn't. FDA's interim policy includes a Category 1 group of nominated bulk substances under evaluation, and enclomiphene citrate remains listed there in FDA's current materials. OPSS also notes that enclomiphene is a component of FDA-approved clomiphene and can be lawfully compounded under section 503A when the legal requirements are met. There is still no FDA-approved enclomiphene drug product.

Compounded vs FDA-approved testosterone: ask which one you'll get

TRT isn't one product. FDA lists approved testosterone as topical gel, transdermal patch, buccal system (a tablet that sticks to your gum), and injection, and FDA-approved oral testosterone capsules also exist. Compounded testosterone creams and injections are a separate category.

The AUA's guideline says commercially manufactured testosterone should be prescribed rather than compounded when possible. It's a conditional recommendation based on low-certainty evidence, so it isn't a ban either. But it's a fair question to ask any program: Is the testosterone I'll get FDA-approved or compounded, and which pharmacy makes it?

As of FDA's June 2026 update, FDA-approved testosterone products are approved for men with low testosterone together with an associated medical condition — like testicular failure from genetic problems or chemotherapy, or a problem with the brain structures that control testosterone (FDA).

Never buy "research chemical" or supplement enclomiphene

The Department of Defense's supplement-safety program says it's illegal to sell clomiphene or enclomiphene as supplement ingredients, yet they still show up on "testosterone booster" labels and on products marked "for research use only" or "not for human consumption." Those aren't a legal patient route, and you have no idea what's actually in the bottle.

---

Side effects and risks: enclomiphene vs TRT

TRT can raise hematocrit, may raise blood pressure, can suppress sperm production, and has product-specific adverse effects that require monitoring. Enclomiphene has no FDA-approved label; current clinic materials list effects such as hot flashes, headache, nausea, fatigue, mood changes and visual symptoms, and estradiol rose in trials. Long-term enclomiphene safety evidence remains limited. See the enclomiphene trial safety data.

Sources: Hone Health's enclomiphene article (company-published side-effect list); Wiehle et al., 2014; AUA guideline statements 9, 11, and 26; FDA, 2025; TRAVERSE; testosterone safety information published by Male Excel.

What TRAVERSE did and didn't show

TRAVERSE enrolled 5,246 men aged 45 to 80 who had heart disease or a high risk of it, symptoms of low testosterone, and two fasting testosterone levels under 300 ng/dL. Testosterone gel was no worse than placebo for major heart events. It did come with more atrial fibrillation, acute kidney injury, and pulmonary embolism. That's reassurance, not a free pass.

Who should not start TRT

The Endocrine Society recommends against testosterone therapy in men who are planning fertility soon, or who have breast or prostate cancer, a prostate lump, a PSA above 4 ng/mL (or above 3 with a high prostate-cancer risk, without a urology workup), a high hematocrit, untreated severe sleep apnea, severe urinary symptoms, uncontrolled heart failure, a heart attack or stroke in the last six months, or a clotting disorder.

Who should not take enclomiphene

There's no FDA label, so there's no official contraindication list. Hone Health publishes its own: don't use it with liver disease, vision or retinal problems, an active hormone-sensitive cancer, or a SERM allergy, and use caution with a history of blood clots, uncontrolled psychiatric conditions, pituitary tumors, or heart disease. Treat that as one company's clinical policy, not a regulatory standard.

What monitoring looks like

• On TRT: a testosterone check after starting, then every 6 to 12 months; hematocrit (the AUA suggests holding off above 50% and acting at 54% or higher); PSA if you're over 40; blood pressure.
• On enclomiphene: the AUA says clinicians using SERMs should monitor testosterone and LH. Many also check estradiol.

---

How much do enclomiphene and TRT cost in 2026?

At the three online programs we checked, published year-one subtotals run from about $1,837 to $2,871 before any unresolved fees, taxes, shipping, or patient-specific medication changes. Compounded enclomiphene is commonly sold cash-pay and coverage is plan-specific; FDA-approved testosterone products may be covered depending on the insurer, diagnosis, prior-authorization rules, pharmacy, and plan.

Year one = start fee + 12 months of membership + 12 months of medication. Shipping and tax aren't included unless noted.

Sources, checked September 20, 2026 unless noted: Taurus landing page, Taurus enclomiphene page, Taurus terms; Hone Plus membership, Hone enclomiphene article; Male Excel homepage, Male Excel pricing, and Male Excel Triclozene.

Our read: Membership and required care can cost more than the medication itself, so a teaser drug price is not the real comparison. Let diagnosis, fertility plans, product type, and the complete written quote drive the decision — not the cheapest monthly number.

The cheapest legal routes (we earn nothing from these)

• FDA-approved generic testosterone through your own doctor. The drug is inexpensive, and insurance may cover visits, labs, and sometimes the prescription, often after prior authorization (your insurer's approval before it pays).
• Generic clomiphene. It's FDA-approved for women's fertility and sometimes prescribed off-label to men. It's an inexpensive generic, but it's a different drug: it contains zuclomiphene, the estrogen-like half.

HSA and FSA

Male Excel says its charges may be eligible for HSA, FSA, or HRA reimbursement. Eligibility and reimbursement depend on the expense and your plan, so confirm with your administrator before you count on it. For a deeper look at enclomiphene pricing specifically, see our enclomiphene provider comparison.

---

Where to get enclomiphene or TRT online: 3 programs we checked

We checked three programs on September 20, 2026. Male Excel is the commercial partner we would compare for men already choosing a cash-pay TRT program with published ongoing monitoring. Hone Health is the clearest public example here of a program offering both single-ingredient compounded enclomiphene and testosterone under one care platform, but it is not treated as an affiliate recommendation on this page. Taurus Meds has the lowest advertised monthly price of these three, but its written terms and sales pages do not fully match.

What we actually verified — September 20, 2026

We checked: Male Excel's homepage, pricing page, and Triclozene page; Hone Health's homepage, membership FAQ, medication list, and enclomiphene article; Taurus Meds' $49 landing page, enclomiphene page, terms, and refund policy; FDA's compounding list (May 14, 2026) and 2022 advisory committee minutes; FDA's testosterone information page (June 2026); HHS's June 2026 labeling request; the DEA's telehealth extension; the AUA, AUA/ASRM, and Endocrine Society guidelines; the 2026 BSSM statement; DoD's supplement-safety guidance; and the main enclomiphene and TRAVERSE trials.

Confirmed from the companies' own pages: each program's published prices and fees; Male Excel's excluded states, 60-day check-ins, 6-month labs, compounded-treatment disclosures, and guarantee; Hone's current $135 Plus and $155 Premium memberships, $45 Plus and $65 Premium starting tests, LH in both current starting panels, enclomiphene from $42, and published follow-up schedules; Taurus's $49 start, $149 advertised price, named partner pharmacies, $17.99 member-fee clause, and written refund policy.

Company claims we didn't test: results, side-effect rates, clinician credentials, shipping speed, and pharmacy quality.

Things we couldn't confirm from public pages: whether Taurus's first test includes LH/FSH; whether Taurus's $17.99 fee applies to the advertised $149 plan at checkout; which SERM description controls for Male Excel's Triclozene because its pages conflict; and the exact pharmacy and patient-specific formulation assigned to every prescription.

What we didn't do: enroll, receive medication, or test any product. This is a comparison built from public documents and company pages, not a hands-on review.

One thing we'd rather you hear from us

Male Excel is a commercial partner for TRT, and it does not present Triclozene as plain single-ingredient enclomiphene. Its pill is a proprietary SERM-and-thyroid blend. On September 20, 2026, Male Excel's own pages disagreed about the main SERM: the product page says enclomiphene citrate, while the current pricing page says clomiphene citrate. We cannot tell from public pages which description controls, so we will not guess. If you specifically want single-ingredient enclomiphene, compare a program that clearly lists that exact compounded medication.

For the man who's already decided on TRT, that tradeoff doesn't touch him. Male Excel's program is built around testosterone, and its $99 membership bundles a provider check-in every 60 days and a full lab panel every 6 months — the kind of ongoing monitoring TRT actually calls for.

The three programs side by side

Male Excel — best for men choosing TRT who want built-in monitoring

Who it fits: You're done having kids, two morning tests confirmed low testosterone, and you want a clinician keeping an eye on things without having to chase appointments.

What Male Excel publishes: A daily under-the-skin testosterone cypionate injection or a twice-daily testosterone cream, plus a $99 monthly membership that includes provider access, check-ins every 60 days, and comprehensive labs every 6 months. Male Excel says it uses its own CLIA-certified lab and names its chief medical officer and medical director. It also publishes testosterone safety information, including the warning that DEA and state law may require an in-person exam.

What to know before you pay:

• Its testosterone is compounded. Male Excel says its testosterone is compounded in the United States. Compounded testosterone isn't FDA-approved, and the AUA prefers commercially manufactured testosterone when possible. If an FDA-approved product matters to you, ask for one — or go local with insurance.
• Thyroid medication is bundled into its listed products. Ask whether it's optional and what lab result supports it for you.
• Its published starting kit doesn't list LH, and its homepage says providers can prescribe before lab results arrive when clinically appropriate. Ask how the clinician will meet diagnostic testing requirements and obtain the labs needed to classify the cause before testosterone therapy is prescribed.
• It doesn't serve 11 states: Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, and Rhode Island.

Year one: $2,727 for injections or $2,871 for cream, plus shipping, based on its published pricing.

Guarantee: Follow your provider's plan for 90 days, and if your symptoms don't improve, Male Excel says it refunds three months of membership fees.

Does that sound like your situation? Start Male Excel's free assessment and check availability in your state → Medication is billed separately from the $99 membership. An assessment doesn't guarantee a prescription.

Hone Health — clearest published enclomiphene-and-TRT menu

Who it may fit: You want a clinician to evaluate a fertility-sensitive low-testosterone question, and you value a program that publishes both enclomiphene and testosterone options plus its current lab panels.

What Hone currently publishes: Single-ingredient compounded enclomiphene from $42 a month on Plus and Premium. Plus is $135 a month and starts with a $45 eight-biomarker test that includes LH; Premium is $155 a month and starts with a $65 comprehensive panel. Testosterone cypionate, compounded cream, and compounded troches are also listed. Hone's Plus non-TRT schedule includes quarterly follow-up labs.

What to know before you pay:

• The membership is the big cost. Plus is $135 a month and Premium is $155 a month, before medication.
• LH is now clearly listed in Hone's current Plus and Premium starting panels. For TRT, Plus also lists a separate confirmatory panel with a second total testosterone measurement, prolactin, PSA, and hematocrit.
• Its enclomiphene article says the drug "preserves fertility." The trials support "kept sperm in range for 16 weeks," which is good news but not a guarantee.
• Homepage testimonials are labeled as compensated. Hone discloses that, which we appreciate. We still don't treat them as evidence.

Credit where it's due: Hone now publishes unusually clear plan-level lab details, including LH in both current men's starting panels and a separate confirmatory pathway for TRT. Its enclomiphene page also publishes a contraindication/precaution list, though those are Hone's clinical policies rather than an FDA-approved enclomiphene label.

Year one: Using current starting prices, Plus with enclomiphene starts at about $2,169 before any patient-specific changes ($45 + 12 × $135 + 12 × $42). Premium with enclomiphene starts at about $2,429 using the $42 medication floor. TRT adds its own medication cost and may require confirmatory testing.

Review Hone's current membership and treatment details → Research link only. A consult doesn't guarantee a prescription.

Taurus Meds — lowest advertised price, but read the fine print

Who it fits: Price is your top filter, you're comfortable with a lab draw at LabCorp or Quest, and you'll get the product, pharmacy, and refund terms in writing before paying.

What you get: A $49 blood test and clinician review, then $149 a month advertised as "all inclusive" for enclomiphene or testosterone. Taurus names its partner pharmacies in its terms (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx) and its management partner, OpenLoop Health. That kind of disclosure is rarer than it should be.

What to know before you pay:

• Its enclomiphene page calls the pill "TRT" and describes it with results from testosterone studies. It also advertises "access to FDA approved medications" and "FDA-certified TRT." Enclomiphene isn't FDA-approved.
• The refund promises don't match. Sales pages mention a money-back guarantee. The written refund policy (updated Feb. 28, 2026) says no refund on cancellation unless a clinician medically disqualifies you, and cancellations need 72 hours' notice before your billing date.
• "No membership fees" vs. the terms. The terms include a $17.99 recurring member fee "unless otherwise stated at the time of purchase." Check your checkout screen.
• Its terms say its services aren't tailored to comply with HIPAA. If health-data privacy is a priority, read the privacy policy before you share records.

Year one: $1,837 at the advertised price, or $2,053 if the $17.99 monthly fee applies.

If price matters most and you'll read the terms first: See Taurus's current price and plan terms → Taurus's published refund/cancellation terms control; confirm what happens to each charge before paying.

If you want insurance or an FDA-approved product

An in-network primary care doctor, urologist, or endocrinologist can evaluate you for an FDA-approved testosterone product and may be able to bill your insurance, depending on your plan and network. Generic testosterone cypionate can be inexpensive at the pharmacy, but visits, labs, prior authorization, and deductibles still matter. This route is especially important when you have a complex history or a red flag below.

Other enclomiphene sellers

Hims (not a partner of ours) advertises enclomiphene plans from $99 a month, all-inclusive. Its testosterone materials also discuss FDA-approved oral testosterone options; current availability should be checked before choosing a plan. If you've settled on enclomiphene and want a wider comparison of sellers, see our enclomiphene provider comparison. For user reports and side-effect patterns, see our enclomiphene reviews.

---

Can you switch from enclomiphene to TRT — or take them together?

Men can move between these therapies, but the change should be clinician-managed. There is no single guaranteed transition timeline in either direction, and recovery of endogenous hormone signaling or sperm production after testosterone varies. There is also not strong evidence that adding enclomiphene to TRT reliably preserves fertility.

Enclomiphene first, TRT later

For a man whose fertility plans are unsettled and whose workup suggests endogenous stimulation may be appropriate, discussing a SERM first can avoid exposing him immediately to exogenous testosterone's suppressive effect on spermatogenesis. If symptoms do not improve, the diagnosis and treatment plan should be reassessed rather than assuming TRT is automatically the next step.

Coming off TRT

Stopping testosterone isn't a flip of a switch. Your brain has to restart LH and FSH, and your testes have to answer. Recovery timelines vary (see the fertility section above). The AUA/ASRM guideline lists SERMs, hCG, and aromatase inhibitors as options specialists may use for infertile men with low testosterone. That's a specialist-guided plan, not a do-it-yourself protocol.

Can you take enclomiphene while on TRT?

Some clinics prescribe the two together. We didn't find strong published evidence that the combination protects fertility, and the AUA/ASRM guideline's answer for men who want kids is simpler: no testosterone. If a clinic suggests a combination, ask what the evidence is, what they'll monitor, and what happens if your sperm count drops anyway.

Never stop, start, or combine these on your own.

---

Can you still get TRT or enclomiphene online after 2026?

Yes, for now. A federal rule lets DEA-registered clinicians prescribe controlled substances like testosterone by telehealth without an in-person visit through December 31, 2026. Enclomiphene isn't a controlled substance, so that rule doesn't apply to it, though state rules and each program's own policies still do.

What happens after December 31, 2026?

We don't know yet, and anyone who says otherwise is guessing. The DEA has extended this rule several times. As of late August 2026, a permanent DEA rule was reportedly under White House review, according to the telehealth advocacy group Alliance for Connected Care. Male Excel already tells patients that DEA and state law may require an in-person exam. If you start TRT online, ask your program what its plan is if the rule changes. We'll update this page when the DEA acts.

Service members and tested athletes

The Department of Defense's supplement-safety program lists enclomiphene and clomiphene on its prohibited list and notes both fall under the World Anti-Doping Agency's hormone-modulator category (DoD OPSS). Testosterone is also banned in tested sport (WADA Prohibited List). If either applies to you, talk to your military treatment facility or your sport's exemption process before starting anything.

---

Who should skip both and see a doctor in person first?

Online hormone programs should not be the default first stop when you are actively trying to conceive, have very low testosterone with a low or low-normal LH, have symptoms that raise concern for pituitary disease, or have a recent major cardiovascular event. Those situations call for primary care, urology, endocrinology, reproductive urology, cardiology, or another appropriate in-person clinician — and possible blood-clot symptoms need emergency evaluation.

Call 911 for chest pain, sudden trouble breathing, or leg pain, swelling, or redness — these can be signs of a blood clot in the lungs or leg.

---

Questions to ask before you pay (screenshot this)

A good program answers these in writing before you pay: which exact drug and form you'll get, whether it's FDA-approved or compounded and which pharmacy makes it, whether your first labs include LH and a second morning test, what you'll pay in month 13, and how to cancel. If you only ask two, ask the first and the fifth.

1. What exactly will I get? Drug name, form, and whether anything else (like thyroid medication) is added.
2. Is it FDA-approved or compounded — and which pharmacy makes it?
3. Do my first labs include LH and FSH? Will you want a second early-morning testosterone test before prescribing?
4. Before TRT, will you check my hematocrit and PSA?
5. What will I pay today, in month 2, and in month 13? Is there a membership or member fee on top?
6. Is there a minimum commitment, and how many days before billing do I need to cancel?
7. What's your refund policy in writing — not the ad version?
8. How often will I see a clinician, and how often are labs repeated?
9. If I might want kids, will you order a semen analysis first?
10. If the telehealth rule changes after December 31, 2026, what happens to my prescription?

---

How we compared enclomiphene and TRT

We read the primary sources — FDA and HHS documents, the DEA rule, the AUA, AUA/ASRM, and Endocrine Society guidelines, and the key trials — and checked each program's own pages on September 20, 2026. We keep verified facts, company claims, and our own judgment separate, and we calculate year-one cost instead of repeating a starting price.

This page follows our published method, How We Review TRT Providers. It looks at clinical eligibility, testing, clinician access, state availability, treatment formats, medication and pharmacy transparency, fertility handling, monitoring, total cost, cancellation, support, and how honest a company's claims are. We don't assign numeric scores, and being listed here isn't an endorsement.

We used Reddit and patient forums only to understand the questions men ask — never as evidence for what works or what's safe.

Why there are no patient testimonials on this page. The quotes on these companies' sites describe how men felt on treatment. We can't verify them, results vary, and one person's experience can't tell you whether enclomiphene or TRT fits your labs. The trials and guidelines are more useful here.

Update log: September 20, 2026 — first published. We'll re-check prices monthly and the DEA rule weekly through December 2026.

---

Enclomiphene vs TRT: frequently asked questions

Is enclomiphene better than TRT?

Neither is better for everyone. Enclomiphene may fit selected men in whom endogenous stimulation is plausible and fertility matters; TRT may fit men for whom testosterone replacement is clinically appropriate. Your diagnosis, the cause of low testosterone, fertility plans, health history, and treatment goals all matter.

Is enclomiphene a type of TRT?

No. TRT replaces testosterone from outside your body. Enclomiphene is a SERM, a pill that signals your own testes to make more testosterone. Some sales pages call it "natural TRT," but it's a different drug with different risks and no FDA approval.

Does enclomiphene shut you down like TRT?

Not in the same way. TRT lowers the brain signals LH and FSH; enclomiphene raises them. In trials lasting up to 16 weeks, sperm counts stayed in the normal range on enclomiphene while they dropped on testosterone gel.

Will TRT make me permanently infertile?

Permanent infertility is not inevitable, but recovery cannot be promised. Data from healthy men in hormonal-contraception studies show sperm production often recovers over time after hormones are stopped, while recovery in men treated for testosterone deficiency is less certain and varies. Talk about fertility before starting testosterone.

Can you take enclomiphene long term?

Long-term evidence is limited. The main enclomiphene trials lasted months, and the British Society for Sexual Medicine notes the lack of long-term efficacy and safety data; its position statement recommends use by experienced clinicians in specialist or research settings.

Is enclomiphene legal and FDA-approved?

There is no FDA-approved enclomiphene drug product. Lawfully compounded enclomiphene may be prescribed when applicable compounding requirements are met, and FDA's current 503A materials continue to list enclomiphene citrate among substances under evaluation. Products sold as dietary supplements or as "research chemicals" are not a lawful substitute for a prescription product.

Is enclomiphene the same as Clomid?

No. Clomid (clomiphene) is an FDA-approved mix of two forms, approved to help women ovulate. Enclomiphene is one of those forms on its own, without zuclomiphene, the part that acts more like estrogen.

How fast does enclomiphene work compared with TRT?

In an early trial, testosterone rose significantly within two weeks on enclomiphene. Symptom timing is less well established. For testosterone therapy, the AUA says clinicians should discuss stopping when testosterone normalizes but symptoms do not improve after three to six months.

Does enclomiphene raise estrogen?

It can. Estradiol rose on enclomiphene in a Phase II trial, similar to testosterone gel. Ask your clinician whether and when to check it, especially if you notice breast tenderness.

Which is cheaper, enclomiphene or TRT?

At the three online programs we checked, published year-one subtotals span roughly $1,837 to $2,871, with unresolved fees or patient-specific medication costs able to change the result. Membership and monitoring can cost more than the medication itself. FDA-approved generic testosterone can be inexpensive at the pharmacy, but visits and labs still matter.

Does insurance cover enclomiphene or TRT?

Compounded enclomiphene is commonly cash-pay, but insurance coverage is plan-specific and should not be stated as impossible. FDA-approved testosterone may be covered, sometimes with prior authorization. Male Excel and Taurus describe cash-pay models; Hone describes a cash-pay membership model and publishes HSA/FSA information for eligible expenses.

Can I switch from TRT to enclomiphene?

Some men switch with clinician guidance, but there is no single recovery timeline or one standard transition protocol. Specialists may use fertility-directed therapies in selected patients. Do not stop or change testosterone on your own.

If I just want a pill, is enclomiphene my only option?

No. FDA-approved oral testosterone capsules exist, but they are still exogenous testosterone and are Schedule III controlled substances. Enclomiphene is a different oral SERM that raises LH and FSH in responsive men; it should not be described as guaranteed to keep normal endogenous production or fertility in every patient.

Can I take enclomiphene and TRT together?

Some clinics prescribe both, but we found no strong evidence that the combination protects fertility. U.S. urology guidelines say men who want kids now or later shouldn't be prescribed testosterone at all.

---

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

You've seen the three questions, the labs, and the costs. If you still can't tell which row you're in, Find My TRT Path maps your situation to the right care route and the questions to ask before you pay. It's educational and non-diagnostic. It doesn't confirm low testosterone, decide eligibility, or guarantee a prescription.

Find My TRT Path →

This page is educational information, not medical advice. Talk with a licensed clinician before starting, stopping, or changing any hormone treatment.

---

Sources

1. American Urological Association. Evaluation and Management of Testosterone Deficiency guideline (2018; 2024 update page) and full text.
2. AUA/ASRM. Diagnosis and Treatment of Infertility in Men (2020; amended 2024).
3. Endocrine Society. Testosterone Therapy in Men With Hypogonadism (2018).
4. British Society for Sexual Medicine. Position Statement on Enclomiphene, World Journal of Men's Health (2026).
5. Wiehle RD, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia. Fertility and Sterility, 2014.
6. Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men. BJU International, 2016.
7. Hohl A, et al. Clomiphene or enclomiphene citrate for male hypogonadism: systematic review and meta-analysis. Archives of Endocrinology and Metabolism, 2025 — publisher summary.
8. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). NEJM, 2023.
9. Liu PY, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception. Lancet, 2006 — summary.
10. Retrospective study of 66 men with infertility after testosterone use, treated with hCG and a SERM (PMC5292276).
11. FDA. Pharmacy Compounding Advisory Committee final summary minutes, June 8, 2022.
12. FDA. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated May 14, 2026).
13. FDA. Class-wide labeling changes for testosterone products, Feb. 28, 2025.
14. FDA. Testosterone Information (current as of June 23, 2026).
15. HHS. Requested updates to testosterone therapy product labels, June 18, 2026.
16. FDA. Potential new indication for testosterone (Federal Register notice), April 2026.
17. DEA/HHS. Fourth Temporary Extension of Telemedicine Flexibilities (through Dec. 31, 2026).
18. DEA. Drug Scheduling.
19. Department of Defense, Operation Supplement Safety. Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements (Jan. 12, 2026).
20. Company pages checked Sept. 20, 2026: Male Excel, Male Excel pricing, Male Excel Triclozene, Hone Health, Hone enclomiphene, Hone medications for men, Hone Plus membership, Taurus landing page, Taurus enclomiphene, Taurus terms, Taurus refund policy.

---

---

21. Hone Health. Hone Plus Membership: Men’s Hormone Optimization with Labs (updated Sept. 10, 2026).
22. World Anti-Doping Agency. 2026 Prohibited List.